Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Airbnb has clawed back 2% on the week to $160.39, but the stock remains down 12% over the past month and sits roughly $23 below the Street's average price target, leaving a gap that analysts are debating rather than closing.
The most active angle this week is analyst activity, and it tells a mixed story. Wells Fargo trimmed its target by $1 to $185 on Wednesday while holding its Overweight rating, a marginal move that signals comfort with the bull case but caution on near-term momentum. Earlier in the week, Keybanc upgraded to Overweight with a $191 target, the most constructive fresh action in recent weeks. Morgan Stanley assumed coverage last month at Equal-Weight with a $170 target, barely above current levels, and Truist Securities holds a Hold with a $161 target that is now nearly at the stock price. The consensus still leans bullish: the mean target is $183.59, implying roughly 14% upside from here, and four analysts carry Outperform-equivalent ratings. But the range from $161 to $220 across recent coverage is unusually wide, reflecting genuine disagreement rather than a settled view.
Short positioning is not the story here. Bears hold 3.5% of the free float, up about 14% in share-count terms over the past month, but still well below any level that would signal crowded conviction. Borrow conditions are loose: availability is running at more than 7,300% of short interest, meaning the lending pool is barely touched. Cost to borrow is just 0.34%, down 29% over the past month. There is no friction for new shorts, but equally no sign they are pressing hard. The ORTEX short score sits at 34.97, middling in the universe and barely changed over the past two weeks. Options tell a slightly more defensive story, but only slightly: the put/call ratio is at 1.05, close to its 20-day average of 1.04 and well within normal range. The 52-week high for the PCR is 1.16, and the current reading is nowhere near that. The defensive tilt flagged in the previous note has largely unwound.
The bull and bear cases on the Street are clearly drawn. Bulls point to accelerating Nights and Seats Booked growth at 10% year-on-year in the second quarter, first-time booker growth at an 11% four-year high, and AI-driven product development cutting concept-to-launch time by up to 60%. Hotels, growing roughly three times faster than the core Homes business, offer a second engine. Bears counter that the model's take rate could flatten near 13.4%, that supply may be approaching a ceiling near current active listing counts, and that weaker assumptions still only produce 8% revenue growth and 36% EBITDA margins. Valuation remains the structural tension: the price-to-earnings multiple sits at 26.8, down over 4 points in a month, and EV/EBITDA has compressed to 15.3, also down on the month. The factor score on EV/EBIT ranks in just the 14th percentile of the universe, meaning Airbnb screens as expensive relative to most peers even after the recent de-rating. Analyst recommendation score, by contrast, ranks in the 100th percentile, the most favoured name in the screen on that measure.
On the ownership side, the three founders remain the largest disclosed holders. Brian Chesky holds roughly 10.8% as last reported, Nathan Blecharczyk around 10.1%, and Joseph Gebbia near 5.1%. Recent insider filings show Blecharczyk made a series of small planned sales on September 28, totalling roughly $2.1 million, all executed under a 10b5-1 plan. Pre-arranged sales under such plans carry less informational weight than discretionary ones. The CFO received a grant on the same date. Net insider activity over the past 90 days shows net selling of around $90.7 million across all insiders, driven primarily by the scale of founder holdings rather than any concentrated discretionary exit.
The most recent earnings print, reported in August, delivered a 1-day move of 17% and a 5-day move of 21%, a sharp reaction that reset the stock sharply higher before the subsequent one-month decline. The next print is scheduled for November 5, now 29 days away. With the stock having retraced much of that August rally and analyst targets clustering between $161 and $200, the question heading into that event is whether the Q3 booking data corroborates the accelerating engagement metrics the bull case depends on.
See the live data behind this article on ORTEX.
Open ABNB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
